Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell, Peripheral × Bevacizumab × 1 year × Clear all

Sponsor

Conditions

Colorectal Neoplasms 117 Carcinoma, Hepatocellular 70 Ovarian Neoplasms 61 Carcinoma, Non-Small-Cell Lung 37 Neoplasms 35 Fallopian Tube Neoplasms 29 Colonic Neoplasms 25 Brain Neoplasms 23 Glioblastoma 19 Breast Neoplasms 19 Neoplasm Metastasis 18 Endometrial Neoplasms 17 Rectal Neoplasms 16 Stomach Neoplasms 15 Uterine Cervical Neoplasms 14 Lung Neoplasms 14 Liver Neoplasms 11 Triple Negative Breast Neoplasms 10 Melanoma 10 Carcinoma, Renal Cell 9 Colorectal Cancer Metastatic 8 Carcinoma, Ovarian Epithelial 8 Recurrence 7 Advanced Solid Tumors 7 Squamous Cell Carcinoma of Head and Neck 6 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Glioma 6 Biliary Tract Neoplasms 6 Small Cell Lung Carcinoma 5 Gastrointestinal Neoplasms 5

Interventions

Cyclophosphamide 13 Prednisone 10 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 9 Doxorubicin 9 Vincristine 8 Gemcitabine 5 Azacitidine 5 romidepsin 4 fludarabine 4 Etoposide 4 Dexamethasone 4 Brentuximab Vedotin 4 belinostat 3 Biopsy 3 10-propargyl-10-deazaaminopterin 3 tazemetostat 2 ruxolitinib 2 pembrolizumab 2 Lenalidomide 2 Bendamustine Hydrochloride 2 venetoclax 1 tislelizumab 1 tipifarnib 1 thymoglobulin 1 sodium-iodide symporter 1 sintilimab 1 selinexor 1 relatlimab 1 pomalidomide 1 parsaclisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡